Join our daily newsletter At The Bell to receive exclusive market insights
- Archer Materials (AXE) achieves a milestone in the development of its biochip, which is being created to detect the world’s most deadly communicable diseases
- The company achieved electronic transport in atom-thin graphene integrated with silicon electronics
- Various voltage ranges were repeatedly recorded on the integrated devices when current-voltage traces were performed
- The work fundamentally links to using a graphene transistor, which the company intends to use in future operations to enable ultrasensitive detection and analysis of diseases
- Shares were trading 10.9 per cent higher today at 96.5 cents each
Archer Materials (AXE) has achieved a milestone in the development of its biochip, which is being created to detect the world’s most deadly communicable diseases.
The company achieved electronic transport in atom-thin graphene integrated with silicon electronics.
Various voltage ranges were repeatedly recorded on the integrated devices when current-voltage traces were performed.
The work fundamentally links to using a graphene transistor, which the company intends to use in future operations to enable ultrasensitive detection and analysis of diseases.
The results of the electronic measurements allow to company to progress into building graphene-based transistors, a requirement for the operation of Archer’s biochip technology.
Chief Executive Officer Dr Mohammad Choucair said it is a milestone step to achieve in the development.
“Archer has now successfully performed complex post-integration lithography and atom-thick materials’ device processing that preserve graphene’s advanced electronic properties,” he said.
“The electronic transport measurements performed by the Archer team are the fundamental link with respect to using graphene in transistor technology intended for future biosensing operations in Archer’s biochip devices.”
Shares were trading 9.77 per cent higher today at 95.5 cents each at 2:13 pm AEDT.
